Cart
sales@molnova.com
KY-226
CAS No. 1621673-53-7
KY-226( —— )
Catalog No. M20927 CAS No. 1621673-53-7
KY-226 is a potent inhibitor of protein tyrosine phosphatase 1B (PTP1B)(IC50: 0.25 μM)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 122 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 431 | In Stock |
|
| 100MG | 690 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKY-226
-
NoteResearch use only, not for human use.
-
Brief DescriptionKY-226 is a potent inhibitor of protein tyrosine phosphatase 1B (PTP1B)(IC50: 0.25 μM)
-
DescriptionKY-226 is a potent inhibitor of protein tyrosine phosphatase 1B (PTP1B)(IC50: 0.25 μM).
-
In VitroWestern Blot Analysis Cell Line:bEnd.3 cells stimulated with LPS Concentration:1 μM Incubation Time:24 hours Result:Rescued lipopolysaccharide-induced reduction of mRNA and protein levels of ZO-1.
-
In VivoAnimal Model:Male db/db mice (8-11 weeks old)Dosage:10 mg/kg and 30 mg/kg Administration:Oral administration; daily; for 4 weeks Result:Significantly reduced plasma glucose and triglyceride levels as well as hemoglobin A1c values without increasing body weight gain.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPTP1B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1621673-53-7
-
Formula Weight481.67
-
Molecular FormulaC27H31NO3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (519.03 mM)
-
SMILESCCCCCCS(=O)(=O)NC(=O)c1ccc(CSCc2ccc(-c3ccccc3)cc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ito Y Fukui M Kanda M et al. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice[J]. Journal of Pharmacological Sciences 2018:S1347861318300422.
molnova catalog
related products
-
SHP099 monohydrochlo...
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.
-
NSC 95397
NSC 95397 is a ?potent inhibitor of Cdc25 dual specificity phosphatase(Ki of 32 96 and 40 nM for Cdc25A Cdc25B and Cdc25C respectively).
-
BCI
BCI is an allosteric inhibitor of dual-specificity phosphatase (DUSP; EC50s: 13.3 and 8.0 μM for DUSP6 and DUSP1 in cells) and does not inhibit DUSP5.
